Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|31|10|550-555

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.10, 2008-09, pp. : 550-555

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

Management of Hepatocellular Carcinoma: From Prevention to Molecular Targeted Therapy

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Hepatocellular Carcinoma 2009 and Beyond: from the Surveillance to Molecular Targeted Therapy

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Indicators for Tumor Recurrence after Liver Transplantation in Hepatocellular Carcinoma and Related Molecular Targeted Therapy

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 116-122

Karger

Access to resources Recommend Favorite